Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis by Lubovich, S, Zaragoza, S, Rodríguez, V, Buendía, J, Vargas, BC, Moreira, JA, Galanternik, L, Ratto, P, Teper, A

Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST by Wenzel, SE, Pavord, I, Zhang, B, Maroni, J, Rowe, P, Hamilton, JD, Swanson, BN, Amin, N, Pirozzi, G, Graham, NM, Teper, A

Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study by Maspero, J, Fitzgerald, M, Pavord, I, Wenzel, S, Zhang, B, Maroni, J, Rowe, P, Amin, N, Pirozzi, G, Ruddy, M, Akinlade, B, Graham, N, Teper, A

Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY... by Pavord, I, Papi, A, Wenzel, S, Park, H, Zhang, B, Staudinger, H, Maroni, J, Rowe, P, Amin, N, Pirozzi, G, Ruddy, M, Akinlade, B, Graham, N, Teper, A

Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study by Castro, M, Corren, J, Hanania, N, Pavord, I, Quirce, S, Thangavelu, K, Rice, M, O'Riordan, T, Maroni, J, Rowe, P, Lu, Y, Amin, N, Ruddy, M, Akinlade, B, Graham, N, Teper, A

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-se... by Busse, WW, Maspero, JF, Rabe, KF, Papi, A, Wenzel, SE, Ford, LB, Pavord, ID, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Akinlade, B, Eckert, L, Chao, J, Graham, NMH, Teper, A

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis by Maspero, JF, Katelaris, CH, Busse, WW, Castro, M, Corren, J, Chipps, BE, Peters, AT, Pavord, ID, Ford, LB, Sher, L, Rabe, KF, Rice, MS, Rowe, P, Lu, Y, Harel, S, Jagerschmidt, A, Khan, A, Kamat, S, Pirozzi, G, Amin, N, Ruddy, M, Graham, NMH, Mannent, L, Teper, A

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma by Castro, M, Corren, J, Pavord, ID, Maspero, JF, Wenzel, SE, Rabe, KF, Busse, WW, Ford, LB, Sher, L, Fitzgerald, JM, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, NMH, Teper, A

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma by Castro, M, Corren, J, Pavord, I, Maspero, J, Wenzel, S, Rabe, K, Busse, W, Ford, L, Sher, L, FitzGerald, J, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, N, Hamilton, J, Swanson, B, Stahl, N, Yancopoulos, G, Teper, A